Hypertension

• 

  Publication Venue For

  • Proportion of US Adults Recommended Out-of-Clinic Blood Pressure Monitoring According to the 2017 Hypertension Clinical Practice Guidelines..  HYPERTENSIONAHA11912775. 2019
  • Animal Models of Hypertension: A Scientific Statement From the American Heart Association..  73:e87-e120. 2019
  • Global REACH 2018: High Blood Viscosity and Hemoglobin Concentration Contribute to Reduced Flow-Mediated Dilation in High-Altitude Excessive Erythrocytosis.  73:1327-1335. 2019
  • Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association..  73:e35-e66. 2019
  • History and Justification of a National Blood Pressure Measurement Validated Device Listing..  73:258-264. 2019
  • Comparative Cost-Effectiveness of Clinic, Home, or Ambulatory Blood Pressure Measurement for Hypertension Diagnosis in US Adults..  73:121-131. 2019
  • Diagnostic Thresholds for Blood Pressure Measured at Home in the Context of the 2017 Hypertension Guideline..  72:1312-1319. 2018
  • Diagnosing Masked Hypertension Using Ambulatory Blood Pressure Monitoring, Home Blood Pressure Monitoring, or Both?.  72:1200-1207. 2018
  • Can We End the Salt Wars With a Randomized Clinical Trial in a Controlled Environment?.  72:10-11. 2018
  • FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study..  72:70-76. 2018
  • Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms..  72:44-55. 2018
  • 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..  71:e13-e115. 2018
  • Angiotensin II Short-Loop Feedback: Is There a Role of Ang II for the Regulation of the Renin System In Vivo?.  71:1075-1082. 2018
  • Day-by-Day Variability of Home Blood Pressure and Incident Cardiovascular Disease in Clinical Practice: The J-HOP Study (Japan Morning Surge-Home Blood Pressure)..  71:177-184. 2018
  • Visit-to-Visit Blood Pressure Variability in Young Adulthood and Hippocampal Volume and Integrity at Middle Age: The CARDIA Study (Coronary Artery Risk Development in Young Adults)..  70:1091-1098. 2017
  • Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin..  70:907-914. 2017
  • Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension..  70:259-266. 2017
  • Hemodynamic and Mechanical Properties of the Proximal Aorta in Young and Middle-Aged Adults With Isolated Systolic Hypertension: The Dallas Heart Study..  70:158-165. 2017
  • Oliver Smithies: A Remembrance..  70:3-4. 2017
  • On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension..  69:220-227. 2017
  • Association Between Long-Term Blood Pressure Variability and 10-Year Progression in Arterial Stiffness: The Multiethnic Study of Atherosclerosis..  69:118-127. 2017
  • Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries: A Systematic Review..  68:1328-1337. 2016
  • Research Needs to Improve Hypertension Treatment and Control in African Americans.  68:1066-1072. 2016
  • Research Needs to Improve Hypertension Treatment and Control in African Americans..  68:1066-1072. 2016
  • A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration..  68:621-629. 2016
  • Regional Fat Distribution and Blood Pressure Level and Variability: The Dallas Heart Study..  68:576-583. 2016
  • Interactions Between the Immune and the Renin-Angiotensin Systems in Hypertension..  68:289-296. 2016
  • Masked Hypertension and Incident Clinic Hypertension Among Blacks in the Jackson Heart Study..  68:220-226. 2016
  • Morning and Evening Home Blood Pressure and Risks of Incident Stroke and Coronary Artery Disease in the Japanese General Practice Population: The Japan Morning Surge-Home Blood Pressure Study..  68:54-61. 2016
  • Visit-to-Visit Variability in Blood Pressure Is Related to Late-Life Cognitive Decline..  68:106-113. 2016
  • Impact of Angiotensin Type 1A Receptors in Principal Cells of the Collecting Duct on Blood Pressure and Hypertension..  67:1291-1297. 2016
  • Longitudinal Patterns of Change in Systolic Blood Pressure and Incidence of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study..  67:1150-1156. 2016
  • Long-Term Blood Pressure Variability, New-Onset Diabetes Mellitus, and New-Onset Chronic Kidney Disease in the Japanese General Population..  66:30-36. 2015
  • Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension..  65:1372-1407. 2015
  • Salt restriction leads to activation of adult renal mesenchymal stromal cell-like cells via prostaglandin E2 and E-prostanoid receptor 4..  65:1047-1054. 2015
  • NADPH oxidase in the renal microvasculature is a primary target for blood pressure-lowering effects by inorganic nitrate and nitrite..  65:161-170. 2015
  • Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension..  64:1275-1281. 2014
  • Linking angiotensin II to nuclear factor-κ light chain enhancer of activated B cells-induced cardiovascular damage: bad CARMAs..  64:933-934. 2014
  • Long-term blood pressure variability throughout young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study..  64:983-988. 2014
  • Improving the prediction of hypertensive target organ damage using novel markers: lessons from retinal vascular imaging research..  64:233-234. 2014
  • Changes in retinal microvascular caliber precede the clinical onset of preeclampsia..  62:899-904. 2013
  • Genome-wide association study meta-analysis reveals transethnic replication of mean arterial and pulse pressure loci..  62:853-859. 2013
  • Hypertensive retinopathy and risk of stroke..  62:706-711. 2013
  • Genetic predisposition to higher blood pressure increases coronary artery disease risk..  61:995-1001. 2013
  • Response to lack of specificity of commercial antibodies leads to misidentification of angiotensin type-1 receptor protein..  61:e32. 2013
  • Temporal changes in retinal microvascular caliber and blood pressure during pregnancy..  61:880-885. 2013
  • Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein..  61:253-258. 2013
  • Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death..  61:166-173. 2013
  • Retinal microvasculature as a model to study the manifestations of hypertension..  60:1094-1103. 2012
  • Blood pressure and retinal microvascular characteristics during pregnancy: Growing Up in Singapore Towards Healthy Outcomes (GUSTO) Study..  60:223-230. 2012
  • Nighttime blood pressure dipping in young adults and coronary artery calcium 10-15 years later: the coronary artery risk development in young adults study..  59:1157-1163. 2012
  • Prehypertension: to treat or not to treat should no longer be the question..  59:e27. 2012
  • Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction..  58:852-858. 2011
  • Treatment intensification in a hypertension telemanagement trial: clinical inertia or good clinical judgment?.  58:552-558. 2011
  • Activation of NADPH oxidase 1 increases intracellular calcium and migration of smooth muscle cells..  58:446-453. 2011
  • Parental history of hypertension is associated with narrower retinal arteriolar caliber in young girls..  58:425-430. 2011
  • Systolic blood pressure, socioeconomic status, and biobehavioral risk factors in a nationally representative US young adult sample..  58:161-166. 2011
  • Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension..  57:577-585. 2011
  • Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure..  55:1331-1338. 2010
  • Angiotensin II type 1 receptor-associated protein is an endogenous inhibitor of angiotensin II type 1 receptor action in cardiac hypertrophy: role in check and balance..  55:1086-1087. 2010
  • Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids..  55:1199-1205. 2010
  • Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis..  55:1210-1216. 2010
  • How does lower education get inside the body to raise blood pressure? What can we do to prevent this?.  55:617-618. 2010
  • The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background..  55:531-538. 2010
  • A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension..  55:99-108. 2010
  • Hypertension improvement project: randomized trial of quality improvement for physicians and lifestyle modification for patients..  54:1226-1233. 2009
  • Quantitative genetic analysis of the retinal vascular caliber: the Australian Twins Eye Study..  54:788-795. 2009
  • Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression..  54:652-658. 2009
  • G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans..  54:71-76. 2009
  • Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis..  53:1023-1031. 2009
  • Effect of birth parameters on retinal vascular caliber: the Twins Eye Study in Tasmania..  53:487-493. 2009
  • A virtuous cycle to improve hypertension outcomes at a national level: linking public health and individualized medicine..  53:105-107. 2009
  • Possible difference in the sympathetic activation on extreme dippers with or without exaggerated morning surge..  53:e1. 2009
  • Eplerenone in patients with acute myocardial infarction complicated by heart failure..  52:e147. 2008
  • Aortic root diameter and longitudinal blood pressure tracking..  52:473-477. 2008
  • Association of parental hypertension with concentrations of select biomarkers in nonhypertensive offspring..  52:381-386. 2008
  • Kidney in hypertension: guyton redux..  51:811-816. 2008
  • Low birthweight is associated with narrower arterioles in adults..  51:933-938. 2008
  • Pediatric antihypertensive trial failures: analysis of end points and dose range..  51:834-840. 2008
  • Safety of placebo controls in pediatric hypertension trials..  51:829-833. 2008
  • Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition..  51:454-459. 2008
  • Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction..  51:48-54. 2008
  • Relationship between retinal arteriolar narrowing and myocardial perfusion: multi-ethnic study of atherosclerosis..  51:119-126. 2008
  • Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis..  50:617-622. 2007
  • Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome..  50:609-616. 2007
  • Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease..  50:474-480. 2007
  • Blood pressure and retinal arteriolar narrowing in children..  49:1156-1162. 2007
  • Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes..  48:1095-1102. 2006
  • Are narrower or wider retinal venules associated with incident hypertension?.  48:e10. 2006
  • Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke..  47:975-981. 2006
  • Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study..  47:861-867. 2006
  • New mass spectrometric assay for angiotensin-converting enzyme 2 activity..  47:1010-1017. 2006
  • Genetic determinants of retinal vascular caliber: additional insights into hypertension pathogenesis..  47:644-645. 2006
  • Blood pressure reactivity to psychological stress: a new risk factor for coronary disease?.  47:329-330. 2006
  • Major clinical trials of hypertension: what should be done next?.  46:1-6. 2005
  • Therapeutic potential of endothelial progenitor cells in cardiovascular diseases..  46:7-18. 2005
  • Management of prehypertension..  45:1056-1061. 2005
  • Role of circulating S-nitrosothiols in control of blood pressure..  45:15-17. 2005
  • Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junction..  44:776-782. 2004
  • Retinal arteriolar narrowing is associated with 5-year incident severe hypertension: the Blue Mountains Eye Study..  44:442-447. 2004
  • Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?.  44:289-293. 2004
  • Sex differences in age-related stiffening of the aorta in subjects with type 2 diabetes..  44:67-71. 2004
  • Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia..  43:988-992. 2004
  • Blood pressure management in patients with acute ischemic stroke..  43:137-141. 2004
  • Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial..  43:393-398. 2004
  • Modifier locus on mouse chromosome 3 for renal vascular pathology in AT1A receptor-deficiency..  43:445-451. 2004
  • Role for thromboxane receptors in angiotensin-II-induced hypertension..  43:364-369. 2004
  • Hypertensive retinal vessel wall signs in a general older population: the Blue Mountains Eye Study..  42:534-541. 2003
  • Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial..  42:459-467. 2003
  • Physiological impact of increased expression of the AT1 angiotensin receptor..  42:507-514. 2003
  • Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension..  42:235-238. 2003
  • AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase..  42:206-212. 2003
  • Effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the pressure-natriuresis relationship..  42:8-13. 2003
  • Blood pressure effects of vitamin C: what's the key question?.  40:789-791. 2002
  • Insulin resistance but not inflammation is associated with gestational hypertension..  40:886-891. 2002
  • Essential role of AT1A receptor in the development of 2K1C hypertension..  40:735-741. 2002
  • Physiological genomics: implications in hypertension research..  39:310-315. 2002
  • Targeted proteomic profiling of renal Na(+) transporter and channel abundances in angiotensin II type 1a receptor knockout mice..  39:470-473. 2002
  • Targeted proteomic profiling of renal Na(+) transporter and channel abundances in angiotensin II type 1a receptor knockout mice..  39:470-473. 2002
  • Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor..  39:116-121. 2002
  • DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension..  38:155-158. 2001
  • Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis..  37:1047-1052. 2001
  • Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction..  35:595-601. 2000
  • Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II..  35:550-554. 2000
  • Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors. 2016
  • Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. 2007